Metabolic syndrome therapy: prevention of vascular injury by antidiabetic agents (Q36062236)

11 August 2017

1 reference

title

Metabolic syndrome therapy: prevention of vascular injury by antidiabetic agents (English)

1 reference

11 August 2017

1 reference

Ligia J Dominguez

1

1 reference

PubMed ID

15748534

11 August 2017

James R Sowers

series ordinal

2

1 reference

11 August 2017

1 April 2005

1 reference

Current Hypertension Reports

11 August 2017

1 reference

11 August 2017

7

1 reference

11 August 2017

2

1 reference

11 August 2017

110-116

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-005-0083-3

11 August 2017

0 references

cites work

Metformin improves vascular function in insulin-resistant rats.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-005-0083-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0083-3

Sulfonylureas stimulate renin secretion from the perfused kidney of the rat

21 January 2018

1 reference

12 December 2020

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

12 December 2020

Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle

1 reference

12 December 2020

Insulin resistance and vascular function

1 reference

12 December 2020

Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM

1 reference

12 December 2020

Insulin and insulin resistance: impact on blood pressure and cardiovascular disease

1 reference

12 December 2020

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

12 December 2020

Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia

1 reference

12 December 2020

Functional roles of KATP channels in vascular smooth muscle

1 reference

12 December 2020

Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective

1 reference

12 December 2020

Role of ATP-sensitive potassium channels in brain stem circulation during hypotension

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

1 reference

12 December 2020

The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Metformin relaxes rat tail artery by repolarization and resultant decreases in Ca2+ influx and intracellular [Ca2+].

1 reference

12 December 2020

Unraveling the mechanism of action of thiazolidinediones

1 reference

12 December 2020

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

12 December 2020

Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes

1 reference

12 December 2020

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

12 December 2020

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity

1 reference

12 December 2020

Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels

1 reference

12 December 2020

Health care and health status and outcomes for patients with type 2 diabetes

1 reference

12 December 2020

Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration.

1 reference

12 December 2020

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

1 reference

12 December 2020

Hyperglycemia as a cardiovascular risk factor

1 reference

12 December 2020

Significant weight gain with rezulin therapy

1 reference

12 December 2020

Rosiglitazone reduces urinary albumin excretion in type II diabetes

1 reference

12 December 2020

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions

1 reference

12 December 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

12 December 2020

Clinical use of thiazolidinediones: recommendations

1 reference

12 December 2020

Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.

1 reference

12 December 2020

Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study

1 reference

12 December 2020

Disparate effects of antidiabetic drugs on arterial contraction

1 reference

12 December 2020

Microcirculatory effects of KATP channel blockade by sulphonylurea derivatives in humans

1 reference

12 December 2020

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

12 December 2020

Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients

1 reference

12 December 2020

Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Effect of K+ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy.

1 reference

12 December 2020

Obesity as a cardiovascular risk factor

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

1 reference

12 December 2020

Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

1 reference

12 December 2020

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

1 reference

12 December 2020

Effects of glibenclamide on blood pressure and cardiovascular responsiveness in non-insulin dependent diabetes mellitus.

1 reference

12 December 2020

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

12 December 2020

Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes

1 reference

12 December 2020

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

12 December 2020

Vascular benefits of gliclazide beyond glycemic control.

1 reference

12 December 2020

Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors

1 reference

12 December 2020

Effects of insulin and metformin on glucose metabolism in rat vascular smooth muscle

1 reference

12 December 2020

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

12 December 2020

10.1007/S11906-005-0083-3

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15748534